[Significance of iron reduction for the therapy of chronic hepatitis C]
Related Experiment Video
Updated: Aug 18, 2026

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
Darko Nozić1, Bela Balint, Nebojsa Stanković
1Vojnomedicinska akademija, Klinika za infektivne i tropske bolesti, Beograd.
Background:
It has been established that many patients with chronic hepatitis C have elevated serum iron, feritin levels and iron deposites in the liver. Therefore, the liver damage due to hepatitis C virus may be aggravated with iron overload. In many studies higher levels of iron in the blood and the liver were connected with the decreased response to interferon-alfa therapy for chronic viral hepatitis C. Recent introduction of pegylated interferons plus ribavirin has improved the therapeutic response, so it is now possible to cure more than 50% of the patients.
Case Report:
Three patients with chronic hepatitis C and iron overload were presented. Iron reduction therapy using phlebotomy or eritrocytapheresis with plasmapheresis was done at different times in regard to specific antiviral therapy or as a sole therapy.
Conclusion:
It has been shown that iron reduction, sole or combined with antiviral therapy, led to the deacreased aminotransferase serum activity and might have slown down the evolution of chronic hepatitis C viral infection.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis
Cirrhosis II: Pathophysiology